Soundos Saleh
R&D Due Diligence Lead
Wuppertal, NW, Germany
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Representation of Older Adult Patients in Clinical Trials.
Journal: Clinical and translational science
Published: August 20, 2025
Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects.
Journal: British journal of clinical pharmacology
Published: June 16, 2025
Pharmacokinetics and Lung Deposition After Administration of Inhaled Mosliciguat (BAY 1237592): Results from Randomized Phase I Studies in Healthy Men.
Journal: Clinical pharmacokinetics
Published: March 23, 2025
Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD study.
Journal: Pulmonary circulation
Published: December 16, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 24, 2021
In vitro-in vivo correlation of the drug-drug interaction potential of antiretroviral HIV treatment regimens on CYP1A1 substrate riociguat.
Journal: Expert opinion on drug metabolism & toxicology
Published: October 18, 2019
Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
Journal: Pulmonary circulation
Published: April 19, 2019
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).
Journal: Clinical drug investigation
Published: September 22, 2018
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.
Journal: Clinical pharmacokinetics
Published: November 01, 2017
Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment.
Journal: Pulmonary circulation
Published: May 11, 2016
Last Updated: 09/26/2026